Skip to Main Content

Paper Details

Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes.
Commun Med (Lond)
5
2023
AD, Alzheimer's disease, Alzheimers disease, Apo-A1, Apo-B, C-reactive protein, CHD, CRP, CVD, Chol, HDL-C, HF, IBD, IDL-C, LDL-, LDL-C, T2DM, TG, VLDL-C, apolipoproteins, atherosclerosis, blockages in blood vessels, blood, cardiovascular disease, carotid plaque, cholesterol, coronary heart disease, diabetes, heart attacks, heart disease, heart failure, inflammatory bowel disease, intermediate, low-density lipoprotein, low-density lipoprotein fractions, people, triglycerides, type 2 diabetes
Author NameAffiliation
Joshua C BisCardiovascular Health Research Unit, University of Washington
Debbie A LawlorBristol Medical School, University of Bristol
Debbie A LawlorBristol Medical School, University of Bristol
Debbie A LawlorNIHR Bristol Biomedical Research Centre, University Hospitals Bristol National Health Service Foundation Trust and University of Bristol
Debbie A LawlorBristol Medical School, University of Bristol
Debbie A LawlorNIHR Bristol Biomedical Research Centre, University Hospitals Bristol National Health Service Foundation Trust and University of Bristol
Debbie A LawlorBristol Medical School, University of Bristol
Jackie F PriceUsher Institute, University of Edinburgh
Nora FranceschiniUniversity of North Carolina
Nora FranceschiniUniversity of North Carolina
Mika KivimäkiUniversity College London
Aroon D HingoraniInstitute of Cardiovascular Science, University College London
Aroon D HingoraniUCL BHF Research Accelerator Centre
  • 1 - 13

Datasets

Release 1.2